Perspective Therapeutics CATX
NYSE CATX
$2.60 -0.02 (-0.76%)
As of: Sep 30, 2026 · 10:22 AM EDT

Perspective Therapeutics (CATX) Common Equity (2011 - 2026)

Updated

Perspective Therapeutics' Common Equity came in at $323.86 million for Q2 2026, up 21.9% from $265.69 million a year earlier but down 6.8% from the prior quarter.

Analysis

Perspective Therapeutics (CATX) Common Equity (2011 - 2026) Analysis & Trends

At the end of FY2025, Perspective Therapeutics' Common Equity was $207.03 million, down 28.8% from FY2024.

  • Common Equity carries a five-year compound annual growth rate of 105.0% (FY2020 to FY2025).
  • Going back by year, Common Equity was $290.67 million in FY2024 (+286.6%), $75.18 million in FY2023 (+37.6%), $54.64 million in FY2022 and $67.41 million in FY2021.
  • The five-year range for quarterly Common Equity is $54.64 million (Q4 2022) to $347.44 million (Q1 2026).
  • Year-over-year, Common Equity increased in five of the last eight quarters, with growth averaging 63.7%.
  • The fastest year-over-year change in Common Equity over five years came in Q4 2024 (growth of 286.6%), and the weakest in Q4 2025 (a decline of 28.8%).
  • Business Quant data shows CATX's Common Equity at $347.44 million (Q1 2026), $207.03 million (Q4 2025) and $242.22 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Perspective Therapeutics 285.22 Mn 285.22 Mn - 323.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 323.86 Mn
Mar 31, 2026 347.44 Mn
Dec 31, 2025 207.03 Mn
Sep 30, 2025 242.22 Mn
Jun 30, 2025 265.69 Mn
Mar 31, 2025 284.65 Mn
Dec 31, 2024 290.67 Mn
Sep 30, 2024 328.47 Mn
Jun 30, 2024 341.00 Mn
Mar 31, 2024 229.89 Mn
Dec 31, 2023 75.18 Mn
Sep 30, 2023 98.77 Mn
Jun 30, 2023 108.65 Mn
Mar 31, 2023 118.03 Mn
Dec 31, 2022 54.64 Mn
Sep 30, 2022 57.70 Mn
Jun 30, 2022 61.28 Mn
Mar 31, 2022 63.20 Mn
Dec 31, 2021 64.39 Mn
Sep 30, 2021 65.76 Mn
API Access

Perspective Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=CATX&period=max&api_key=YOUR_API_KEY